Samsung is testing Galaxy Watch 8 to prevent muscle loss on GLP-1s like Ozempic - Engadget
Briefly

Samsung is testing Galaxy Watch 8 to prevent muscle loss on GLP-1s like Ozempic - Engadget
Samsung partnered with the Massachusetts General Hospital Diabetes Research Center to investigate whether wearables can help people using GLP-1 manage muscle loss. The study will use Galaxy Watch 8 and Samsung Health to collect biometric data, including body composition, activity levels, and heart rate. The partnership is motivated by widespread GLP-1 use among US adults for type 2 diabetes and weight loss. Medical concerns include that more than 30% of weight loss on GLP-1 can come from muscle, and that patients may not regain muscle after stopping treatment. Researchers also link lean body mass loss to higher cardiovascular disease risk and reduced quality of life. The study will enroll 100 adults beginning GLP-1 therapy and assign them to two groups.
"Samsung has teamed up with the Massachusetts General Hospital (MGH) Diabetes Research Center to investigate how wearables can help people on GLP-1 manage muscle loss. They're specifically using Galaxy Watch 8, which the company released last year, for their study. Samsung says the study will focus on investigating the "feasibility of managing muscle loss for GLP-1 patients by utilizing biometric data including body composition, activity levels and heart rate provided by Galaxy Watch and Samsung Health.""
"In its announcement, the company has referenced a KFF poll that says nearly one in five adults in the US has taken a GLP-1 drug at some point to manage Type 2 diabetes and to lose weight. With that many people using the medication, it's no surprise that companies like Samsung would want to incorporate features that would serve them into their products."
"Over 30 percent of weight loss on the medication can be from muscle, he wrote. And while it's not that different from the muscle loss one experiences with other weight-loss methods, scientists are worried that patients aren't always regaining that muscle when they regain weight after stopping treatment."
"Researchers from the University of Virginia conducted a study into muscle loss from GLP-1 drugs and determined that it could undermine long-term health. "This is a serious concern. Muscle, especially axial muscle, is essential for posture, physical function and overall well-being," they wrote. They explained that losing lean body mass increases the risk of cardiovascular diseases, which could lead to diminished quality of life."
Read at Engadget
Unable to calculate read time
[
|
]